People with fever, pregnant and breastfeeding women avoid
Bharat Biotechs fact sheet onCOVID-19 vaccine Covaxin, has advised pregnant orbreastfeeding women, besides people with high fever orbleeding disorders, not to take the antidote.The vaccine maker in the fact sheet on Covaxin, posted inits website, said the clinical efficacy of the vaccine is yetto be established and is being studied in Phase 3 clinicaltrial and hence it is important to appreciate that receivingthe vaccine does not mean other precautions related to COVID-19 need not be followed.You should not get Bharat Biotechs COVID-19 vaccineCovaxin if you have any history of allergies.
PTI | Hyderabad | Updated: 19-01-2021 11:28 IST | Created: 19-01-2021 11:28 IST
Bharat Biotech's fact sheet onCOVID-19 vaccine Covaxin, has advised pregnant orbreastfeeding women, besides people with high fever orbleeding disorders, not to take the antidote.
The vaccine maker in the fact sheet on Covaxin, posted inits website, said the clinical efficacy of the vaccine is yetto be established and is being studied in Phase 3 clinicaltrial and hence it is important to appreciate that receivingthe vaccine does not mean other precautions related to COVID-19 need not be followed.
''You should not get Bharat Biotech's COVID-19 vaccineCovaxin if you have any history of allergies. Have high fever.
Have bleeding disorder or are a blood thinner.
Immune compromised or are a medicine that affects yourimmune system. Are pregnant. Are breast feeding.
Have received another COVID-19 vaccine. Any other serioushealth related issues, as determined by the vaccinator/Officer supervising vaccination,'' the fact sheet said.
The fact sheet also asked people to inform the vaccinatoror a supervising official about their medical condition beforetaking the vaccine.
Bharat Biotech said in an ongoing clinical trial Covaxinhas been shown to generate immunity following two doses givenfour weeks apart.
Covaxin is a vaccine with approval for restricted use inemergency situations that may prevent COVID-19.
The Central Licensing Authority has granted permissionfor the sale or distribution of the antidote for restricteduse in emergency situations in public interest as an abundantprecaution, in clinical trial mode, the fact sheet said.
Covaxin is a highly purified and inactivated two-doseSARS-CoV-2 vaccine, manufactured in a Vero cell manufacturingplatform with an excellent safety track record of more than300 million doses, the company had said.
Covaxin is India's totally indigenous COVID-19 vaccinedeveloped in collaboration with the Indian Council of MedicalResearch and National Institute of Virology.
The inactivated vaccine is developed and manufactured inBharat Biotech's BSL-3 (Bio-Safety Level 3) biocontainmentfacility, one of its kind in the world.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Bharat Biotech setting up 4 vaccine manufacturing facilities
Bharat Biotech MD questions experts' silence over UK trials of Covid-19 vaccine
Bharat Biotech setting up 4 vaccine manufacturing facilities
Indian companies do not deserve this backlash, Covaxin is simple two doses, says Bharat Biotech Chairman
Covaxin is 200% safe, says Bharat Biotech Chairman